Copyright Reports & Markets. All rights reserved.

Global Chorea Treatment Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global Chorea Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Chorea Treatment Market Size 2014-2024
        • 2.1.2 Chorea Treatment Market Size CAGR by Region
      • 2.2 Chorea Treatment Segment by Type
        • 2.2.1 Medication
        • 2.2.2 Surgery Therapy
      • 2.3 Chorea Treatment Market Size by Type
        • 2.3.1 Global Chorea Treatment Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Chorea Treatment Market Size Growth Rate by Type (2014-2019)
      • 2.4 Chorea Treatment Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Others
      • 2.5 Chorea Treatment Market Size by Application
        • 2.5.1 Global Chorea Treatment Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Chorea Treatment Market Size Growth Rate by Application (2014-2019)

      3 Global Chorea Treatment by Players

      • 3.1 Global Chorea Treatment Market Size Market Share by Players
        • 3.1.1 Global Chorea Treatment Market Size by Players (2017-2019)
        • 3.1.2 Global Chorea Treatment Market Size Market Share by Players (2017-2019)
      • 3.2 Global Chorea Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Chorea Treatment by Regions

      • 4.1 Chorea Treatment Market Size by Regions
      • 4.2 Americas Chorea Treatment Market Size Growth
      • 4.3 APAC Chorea Treatment Market Size Growth
      • 4.4 Europe Chorea Treatment Market Size Growth
      • 4.5 Middle East & Africa Chorea Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Chorea Treatment Market Size by Countries
      • 5.2 Americas Chorea Treatment Market Size by Type
      • 5.3 Americas Chorea Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Chorea Treatment Market Size by Countries
      • 6.2 APAC Chorea Treatment Market Size by Type
      • 6.3 APAC Chorea Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Chorea Treatment by Countries
      • 7.2 Europe Chorea Treatment Market Size by Type
      • 7.3 Europe Chorea Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Chorea Treatment by Countries
      • 8.2 Middle East & Africa Chorea Treatment Market Size by Type
      • 8.3 Middle East & Africa Chorea Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Chorea Treatment Market Forecast

      • 10.1 Global Chorea Treatment Market Size Forecast (2019-2024)
      • 10.2 Global Chorea Treatment Forecast by Regions
        • 10.2.1 Global Chorea Treatment Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Chorea Treatment Forecast by Type
      • 10.8 Global Chorea Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 Medtronic
        • 11.1.1 Company Details
        • 11.1.2 Chorea Treatment Product Offered
        • 11.1.3 Medtronic Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Medtronic News
      • 11.2 Boston Scientific
        • 11.2.1 Company Details
        • 11.2.2 Chorea Treatment Product Offered
        • 11.2.3 Boston Scientific Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Boston Scientific News
      • 11.3 Aleva Neurotherapeutics
        • 11.3.1 Company Details
        • 11.3.2 Chorea Treatment Product Offered
        • 11.3.3 Aleva Neurotherapeutics Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Aleva Neurotherapeutics News
      • 11.4 Teva Pharmaceutical
        • 11.4.1 Company Details
        • 11.4.2 Chorea Treatment Product Offered
        • 11.4.3 Teva Pharmaceutical Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Teva Pharmaceutical News
      • 11.5 Pfizer
        • 11.5.1 Company Details
        • 11.5.2 Chorea Treatment Product Offered
        • 11.5.3 Pfizer Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Pfizer News
      • 11.6 GlaxoSmithKline
        • 11.6.1 Company Details
        • 11.6.2 Chorea Treatment Product Offered
        • 11.6.3 GlaxoSmithKline Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 GlaxoSmithKline News
      • 11.7 Bausch Health Companies
        • 11.7.1 Company Details
        • 11.7.2 Chorea Treatment Product Offered
        • 11.7.3 Bausch Health Companies Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Bausch Health Companies News
      • 11.8 LivaNova
        • 11.8.1 Company Details
        • 11.8.2 Chorea Treatment Product Offered
        • 11.8.3 LivaNova Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 LivaNova News
      • 11.9 Lundbeck
        • 11.9.1 Company Details
        • 11.9.2 Chorea Treatment Product Offered
        • 11.9.3 Lundbeck Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Lundbeck News
      • 11.10 Ipsen
        • 11.10.1 Company Details
        • 11.10.2 Chorea Treatment Product Offered
        • 11.10.3 Ipsen Chorea Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Ipsen News
      • 11.11 Alnylam Pharmaceuticals
      • 11.12 Prana Biotechnology
      • 11.13 RespireRx Pharmaceuticals
      • 11.14 Vertex Pharmaceuticals
      • 11.15 SOM Biotech

      12 Research Findings and Conclusion

      Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.

      According to this study, over the next five years the Chorea Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Chorea Treatment business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Chorea Treatment market by product type, application, key companies and key regions.

      This study considers the Chorea Treatment value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Medication
      Surgery Therapy
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Hospitals
      Clinics
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Medtronic
      Boston Scientific
      Aleva Neurotherapeutics
      Teva Pharmaceutical
      Pfizer
      GlaxoSmithKline
      Bausch Health Companies
      LivaNova
      Lundbeck
      Ipsen
      Alnylam Pharmaceuticals
      Prana Biotechnology
      RespireRx Pharmaceuticals
      Vertex Pharmaceuticals
      SOM Biotech

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Chorea Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Chorea Treatment market by identifying its various subsegments.
      Focuses on the key global Chorea Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Chorea Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Chorea Treatment submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now